Gufic BioSciences Share Price
18 Nov, 2026 3:54 PM (IST)
Gufic BioSciences Performance
- Today's Low
- ₹421
- Today's High
- ₹442
- 52 Week Low
- ₹268
- 52 Week High
- ₹494
- Open Price₹442
- Previous Close₹440
- Volume162,346
- 50 DMA₹425.90
- 100 DMA₹408.90
- 200 DMA₹385.40
Gufic BioSciences Chart
Investment Returns
- Over 1 Month + 4.39%
- Over 3 Month + 0.2%
- Over 6 Month + 52.38%
- Over 1 Year + 28.19%
Smart Investing Starts Here Start SIP with Gufic BioSciences for Steady Growth!
Gufic BioSciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 52.9
- PEG Ratio
- 1.3
- Market Cap Cr
- 4,234
- P/B Ratio
- 6.2
- Average True Range
- 23
- EPS
- 8
- Dividend Yield
- 0
- MACD Signal
- 8.5
- RSI
- 46.03
- MFI
- 65.68
Latest Stock News Updates
Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith
- BSE India
- 2 days 13 hours ago
<h3><span style="font-size:16px;"><strong>Pharmaceuticals company Gufic BioSciences announced Q2FY27 results</strong></span></h3> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gZfvmc_1l"> <li data-complete="true" data-hveid="CAAIChAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_1m"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_1o">Revenue from operations:<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated revenue from operations stood at Rs 28,827.30 lakh, registering a growth of 10.53% QoQ from Rs 26,081.80 lakh in Q1FY27 and an increase of 21.61% YoY from Rs 23,705.45 lakh in Q2FY26. For H1FY27, consolidated revenue from operations grew by 19.17% YoY to Rs 54,909.10 lakh compared to Rs 46,077.70 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_1u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_1w">Total income:<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated total income stood at Rs 28,939.77 lakh, up 10.76% QoQ from Rs 26,127.55 lakh in Q1FY27 and up 21.00% YoY from Rs 23,917.00 lakh in Q2FY26. For H1FY27, consolidated total income rose by 18.73% YoY to Rs 55,067.32 lakh from Rs 46,381.77 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_22"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_24">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated PBT increased by 4.69% QoQ to Rs 3,144.74 lakh from Rs 3,003.94 lakh in Q1FY27 and rose by 39.12% YoY from Rs 2,260.41 lakh in Q2FY26. For H1FY27, consolidated PBT grew by 54.19% YoY to Rs 6,148.68 lakh from Rs 3,987.82 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2a"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_2c">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated total profit for the period rose by 5.18% QoQ to Rs 2,346.89 lakh from Rs 2,231.28 lakh in Q1FY27 and increased by 39.50% YoY from Rs 1,682.40 lakh in Q2FY26. For H1FY27, consolidated total profit for the period grew by 53.14% YoY to Rs 4,578.17 lakh compared to Rs 2,989.44 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2i"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_2k">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> In Q2FY27, consolidated basic and diluted EPS rose by 5.41% QoQ to Rs 2.34 from Rs 2.22 in Q1FY27 and grew by 39.29% YoY from Rs 1.68 in Q2FY26. For H1FY27, consolidated basic and diluted EPS increased by 53.36% YoY to Rs 4.57 from Rs 2.98 in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <!--TgQPHd|||[]--> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDRAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="gZfvmc_2x"> <li data-complete="true" data-hveid="CAAIDRAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_2y"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_30">Revenue from operations:<!--TgQPHd|||[]--></strong> In Q2FY27, standalone revenue from operations stood at Rs 28,840.15 lakh, increasing by 10.58% QoQ from Rs 26,081.80 lakh in Q1FY27 and growing by 25.16% YoY from Rs 23,041.80 lakh in Q2FY26. For H1FY27, standalone revenue from operations rose by 20.09% YoY to Rs 54,921.95 lakh from Rs 45,732.95 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAE" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_36"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_38">Total income:<!--TgQPHd|||[]--></strong> In Q2FY27, standalone total income stood at Rs 28,952.62 lakh, up 10.81% QoQ from Rs 26,127.55 lakh in Q1FY27 and up 24.52% YoY from Rs 23,250.85 lakh in Q2FY26. For H1FY27, standalone total income grew by 19.66% YoY to Rs 55,080.17 lakh from Rs 46,031.42 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAH" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3e"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3g">Profit before tax (PBT):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone PBT increased by 4.41% QoQ to Rs 3,149.25 lakh from Rs 3,016.20 lakh in Q1FY27 and rose by 53.41% YoY from Rs 2,052.86 lakh in Q2FY26. For H1FY27, standalone PBT surged by 67.51% YoY to Rs 6,165.45 lakh from Rs 3,680.56 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAK" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3m"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3o">Profit after tax (PAT):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone total profit for the period rose by 4.58% QoQ to Rs 2,348.86 lakh from Rs 2,246.05 lakh in Q1FY27 and increased by 57.25% YoY from Rs 1,493.71 lakh in Q2FY26. For H1FY27, standalone total profit for the period jumped by 70.12% YoY to Rs 4,594.91 lakh from Rs 2,701.04 lakh in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDRAN" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="gZfvmc_3u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="gZfvmc_3w">Earnings per share (EPS):<!--TgQPHd|||[]--></strong> In Q2FY27, standalone basic and diluted EPS increased by 4.46% QoQ to Rs 2.34 from Rs 2.24 in Q1FY27 and grew by 57.05% YoY from Rs 1.49 in Q2FY26. For H1FY27, standalone basic and diluted EPS rose by 70.26% YoY to Rs 4.58 from Rs 2.69 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5953353/" target="_blank">Result PDF</a></p>
- Trendlyne
- 2 days 15 hours ago
Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026 is attached herewith
- BSE India
- 2 days 20 hours ago
Gufic BioSciences Financials
Gufic BioSciences Technicals
EMA & SMA
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹437.20
- 50 Day
- ₹425.90
- 100 Day
- ₹408.90
- 200 Day
- ₹385.40
Resistance and Support
- R3 456.80
- R2 449.40
- R1 435.80
- S1 414.80
- S2 407.40
- S3 393.90
Gufic BioSciences Corporate Actions - Bonus, Splits, Dividends
About Gufic BioSciences
Gufic BioSciences engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. View More- NSE Symbol
- GUFICBIO
- BSE Symbol
- 509079
- ISIN
- INE742B01025
Similar Stocks to Gufic BioSciences
Popular Stocks
Gufic BioSciences FAQs
Gufic BioSciences share price is ₹422 As on 19 November, 2026 | 08:09
The Market Cap of Gufic BioSciences is ₹4234.4 Cr As on 19 November, 2026 | 08:09
The P/E ratio of Gufic BioSciences is 52.9 As on 19 November, 2026 | 08:09
The PB ratio of Gufic BioSciences is 6.2 As on 19 November, 2026 | 08:09
The 52 week High & Low of Gufic BioSciences is ₹494/₹268 respectively As on 19 November, 2026 | 08:09
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.